TLT:TSXV, Theralase Technologies Inc.

TLT stock overview

Theralase Technologies Inc. (TLT:TSXV) closed at $0.210 on October 23, 2026, down 4.55% on the day. The stock trades 48.8% below its 52-week high of $0.410 and 40.0% above its 52-week low of $0.150. Theralase Technologies Inc. is part of the Life Sciences sector (Healthcare Facilities and Equipment).

Key figures

Price
$0.210
Day change
-4.55%
Volume
512,773
Average volume
242,961
Market cap
65M+
52-week range
$0.150 – $0.410
50-day average
$0.186
200-day average
$0.248

Price action over the past year

In 252 trading sessions since October 23, 2025, TLT closed higher on 71 days (28%). Its best day was May 8, 2026 (+30.43%) and its worst was May 6, 2026 (-21.43%). The stock moved 10% or more in a single session 19 times. It opened at least 5% above the previous day's high 7 times.

TLT news

About Theralase Technologies Inc.

Theralase Technologies Inc designs, develops, manufactures, markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain and also develops patented and patent pending drugs, called Photo Dynamic Compounds.

Similar stocks

Find more stocks like TLT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.